INTRODUCTION: Despite the significant impact of type 1 diabetes (T1D) on family, few instruments are available to assess health-related quality of life (HRQOL) among family members of people with T1D. This study aimed to develop and evaluate the psychometric properties of new measures of diabetes-specific HRQOL for parents and partners of people with T1D. We report on the multistep development and validation process for the self-report Type 1 Diabetes and Life (T1DAL) measures, with versions for parents of youth age <8, 8-11, 12-17, and 18-25 years, and for partners of people age ≥18 years with T1D. METHOD: First, we conducted qualitative interviews (total parents/partners n = 38) to develop draft measures and piloted them (total n = 20). Next, we tested the measures' psychometric properties. Participants (total across versions n = 813) at six T1D Exchange Clinic Network sites completed the appropriate T1DAL measure and validated measures of related constructs. We then reduced each T1DAL measure to 20-30 items in length based on psychometric data and participant feedback. Eleven participants reviewed the final measures via cognitive debriefing. RESULTS: The T1DAL measures for parents and partners demonstrated good internal consistency (α = .80-.88) and test-retest reliability (r = .73-.86). Correlations with measures of general quality of life, generic and diabetes-specific HRQOL, and diabetes burden demonstrated construct validity. Factor analyses identified 3-4 subscales/measure. Participants reported being satisfied with the shortened measures, which took 5-10 minutes to complete. DISCUSSION: The new T1DAL measures for parents and partners of people with T1D are reliable, valid, and ready for use in research and clinical settings. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
INTRODUCTION: Despite the significant impact of type 1 diabetes (T1D) on family, few instruments are available to assess health-related quality of life (HRQOL) among family members of people with T1D. This study aimed to develop and evaluate the psychometric properties of new measures of diabetes-specific HRQOL for parents and partners of people with T1D. We report on the multistep development and validation process for the self-report Type 1 Diabetes and Life (T1DAL) measures, with versions for parents of youth age <8, 8-11, 12-17, and 18-25 years, and for partners of people age ≥18 years with T1D. METHOD: First, we conducted qualitative interviews (total parents/partners n = 38) to develop draft measures and piloted them (total n = 20). Next, we tested the measures' psychometric properties. Participants (total across versions n = 813) at six T1D Exchange Clinic Network sites completed the appropriate T1DAL measure and validated measures of related constructs. We then reduced each T1DAL measure to 20-30 items in length based on psychometric data and participant feedback. Eleven participants reviewed the final measures via cognitive debriefing. RESULTS: The T1DAL measures for parents and partners demonstrated good internal consistency (α = .80-.88) and test-retest reliability (r = .73-.86). Correlations with measures of general quality of life, generic and diabetes-specific HRQOL, and diabetes burden demonstrated construct validity. Factor analyses identified 3-4 subscales/measure. Participants reported being satisfied with the shortened measures, which took 5-10 minutes to complete. DISCUSSION: The new T1DAL measures for parents and partners of people with T1D are reliable, valid, and ready for use in research and clinical settings. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
Authors: Alan M Delamater; Maartje de Wit; Vincent McDarby; Jamil A Malik; Marisa E Hilliard; Elisabeth Northam; Carlo L Acerini Journal: Pediatr Diabetes Date: 2018-10 Impact factor: 4.866
Authors: Paula M Trief; Yawen Jiang; Roy Beck; Peter J Huckfeldt; Tara Knight; Kellee M Miller; Ruth S Weinstock Journal: J Health Psychol Date: 2016-07-10
Authors: Marisa E Hilliard; Wendy Levy; Barbara J Anderson; Amanda L Whitehouse; Persis V Commissariat; Kara R Harrington; Lori M Laffel; Kellee M Miller; Michelle Van Name; William V Tamborlane; Daniel J DeSalvo; Linda A DiMeglio Journal: Diabetes Technol Ther Date: 2019-07-09 Impact factor: 6.118
Authors: Adam B Lewin; Annette M LaGreca; Gary R Geffken; Laura B Williams; Danny C Duke; Eric A Storch; Janet H Silverstein Journal: J Pediatr Psychol Date: 2009-05-07
Authors: Sarah S Jaser; Nicole C Foster; Bryce A Nelson; Julie M Kittelsrud; Linda A DiMeglio; Maryanne Quinn; Steven M Willi; Jill H Simmons Journal: Sleep Med Date: 2017-07-18 Impact factor: 3.492
Authors: Marisa E Hilliard; Charles G Minard; David G Marrero; Maartje de Wit; Debbe Thompson; Stephanie N DuBose; Alandra Verdejo; Roshanak Monzavi; R Paul Wadwa; Sarah S Jaser; Barbara J Anderson Journal: J Pediatr Psychol Date: 2020-04-01
Authors: J Weissberg-Benchell; J B Shapiro; K Hood; L M Laffel; D Naranjo; K Miller; K Barnard Journal: Diabet Med Date: 2019-03-20 Impact factor: 4.359